NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of $106.90 million. The enterprise value is $128.25 million.
| Market Cap | 106.90M |
| Enterprise Value | 128.25M |
Important Dates
The next estimated earnings date is Friday, July 24, 2026.
| Earnings Date | Jul 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 840.07 million shares outstanding. The number of shares has increased by 37.20% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 840.07M |
| Shares Change (YoY) | +37.20% |
| Shares Change (QoQ) | +17.08% |
| Owned by Insiders (%) | 3.81% |
| Owned by Institutions (%) | 25.89% |
| Float | 843.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.03 |
| Forward PS | 35.34 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 22.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.07 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.39 |
Financial Efficiency
Return on equity (ROE) is -61.97% and return on invested capital (ROIC) is -13.86%.
| Return on Equity (ROE) | -61.97% |
| Return on Assets (ROA) | -12.82% |
| Return on Invested Capital (ROIC) | -13.86% |
| Return on Capital Employed (ROCE) | -26.19% |
| Weighted Average Cost of Capital (WACC) | 9.36% |
| Revenue Per Employee | $29,256 |
| Profits Per Employee | -$482,944 |
| Employee Count | 192 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 1.26 |
Taxes
In the past 12 months, NOVONIX has paid $25,542 in taxes.
| Income Tax | 25,542 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.89% in the last 52 weeks. The beta is 0.93, so NOVONIX's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -55.89% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 39.65 |
| Average Volume (20 Days) | 454,470 |
Short Selling Information
The latest short interest is 4.04 million, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 4.04M |
| Short Previous Month | 4.02M |
| Short % of Shares Out | 1.89% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.93 |
Income Statement
In the last 12 months, NOVONIX had revenue of $5.62 million and -$92.73 million in losses. Loss per share was -$0.14.
| Revenue | 5.62M |
| Gross Profit | 3.12M |
| Operating Income | -52.22M |
| Pretax Income | -92.70M |
| Net Income | -92.73M |
| EBITDA | -48.32M |
| EBIT | -52.22M |
| Loss Per Share | -$0.14 |
Balance Sheet
The company has $79.87 million in cash and $100.34 million in debt, with a net cash position of -$20.47 million or -$0.02 per share.
| Cash & Cash Equivalents | 79.87M |
| Total Debt | 100.34M |
| Net Cash | -20.47M |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 161.67M |
| Book Value Per Share | 0.19 |
| Working Capital | 5.60M |
Cash Flow
In the last 12 months, operating cash flow was -$42.20 million and capital expenditures -$60.18 million, giving a free cash flow of -$102.38 million.
| Operating Cash Flow | -42.20M |
| Capital Expenditures | -60.18M |
| Depreciation & Amortization | 3.90M |
| Net Borrowing | 93.20M |
| Free Cash Flow | -102.38M |
| FCF Per Share | -$0.12 |
Margins
| Gross Margin | 55.49% |
| Operating Margin | -929.63% |
| Pretax Margin | -1,650.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.20% |
| Shareholder Yield | -37.20% |
| Earnings Yield | -86.74% |
| FCF Yield | -95.77% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 198.90% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NOVONIX has an Altman Z-Score of -1.22 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.22 |
| Piotroski F-Score | 2 |